{
  "submitter" : "Reach",
  "model_relation" : "extension",
  "extracted_information" : {
    "interaction_type" : "decreases_activity",
    "negative_information" : false,
    "participant_b" : {
      "in_model" : true,
      "identifier" : "uniprot:P56524",
      "entity_text" : "HDAC4",
      "entity_type" : "protein"
    },
    "participant_a" : {
      "in_model" : true,
      "identifier" : "uaz:UAZ04793",
      "entity_text" : "tasquinimod",
      "entity_type" : "protein"
    },
    "hypothesis_information" : false
  },
  "verbose_text" : "In contrast to other angiogenesis inhibitors targeting VEGF and/or tyrosine kinases receptors, tasquinimod disrupts cross talk within the tumour microenvironment by modulating HDAC4 and also targets S100A9.",
  "reading_complete" : "2020-08-04T13:33:07Z",
  "reader_type" : "machine",
  "reading_started" : "2020-08-04T13:31:45Z",
  "trigger" : "disrupts",
  "evidence" : [ "tasquinimod disrupts cross talk within the tumour microenvironment by modulating HDAC4" ],
  "pmc_id" : "4708177",
  "score" : 0
}